BlueMountain Capital Management LLC grew its position in Danaher Corporation (NYSE:DHR) by 58.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 22,035 shares of the conglomerate’s stock after purchasing an additional 8,119 shares during the quarter. BlueMountain Capital Management LLC’s holdings in Danaher Corporation were worth $1,860,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. Norway Savings Bank raised its position in shares of Danaher Corporation by 0.4% in the second quarter. Norway Savings Bank now owns 2,238 shares of the conglomerate’s stock valued at $189,000 after purchasing an additional 10 shares during the period. First Financial Corp IN raised its position in shares of Danaher Corporation by 0.8% in the second quarter. First Financial Corp IN now owns 2,720 shares of the conglomerate’s stock valued at $230,000 after purchasing an additional 21 shares during the period. Brighton Jones LLC raised its position in shares of Danaher Corporation by 0.4% in the second quarter. Brighton Jones LLC now owns 5,159 shares of the conglomerate’s stock valued at $435,000 after purchasing an additional 21 shares during the period. Guardian Life Insurance Co. of America raised its position in shares of Danaher Corporation by 1.0% in the first quarter. Guardian Life Insurance Co. of America now owns 2,356 shares of the conglomerate’s stock valued at $202,000 after purchasing an additional 24 shares during the period. Finally, Buckingham Asset Management LLC raised its position in shares of Danaher Corporation by 0.4% in the second quarter. Buckingham Asset Management LLC now owns 5,778 shares of the conglomerate’s stock valued at $488,000 after purchasing an additional 24 shares during the period. 75.66% of the stock is currently owned by institutional investors.

In related news, Director Linda P. Hefner sold 10,578 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now owns 42,151 shares in the company, valued at $3,499,797.53. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider William King sold 7,458 shares of the firm’s stock in a transaction on Friday, July 21st. The stock was sold at an average price of $82.97, for a total value of $618,790.26. Following the completion of the transaction, the insider now owns 18,245 shares in the company, valued at approximately $1,513,787.65. The disclosure for this sale can be found here. Insiders have sold a total of 71,496 shares of company stock worth $5,916,223 in the last quarter. Company insiders own 12.20% of the company’s stock.

A number of equities analysts recently issued reports on the stock. Wells Fargo & Company reaffirmed a “market perform” rating on shares of Danaher Corporation in a research report on Saturday, July 22nd. Cowen and Company reaffirmed a “buy” rating and set a $90.00 target price on shares of Danaher Corporation in a research report on Wednesday, October 4th. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 target price on shares of Danaher Corporation in a research report on Friday, August 4th. BidaskClub lowered shares of Danaher Corporation from a “hold” rating to a “sell” rating in a research report on Tuesday, July 25th. Finally, Morgan Stanley reaffirmed an “overweight” rating and set a $95.00 target price (up previously from $86.00) on shares of Danaher Corporation in a research report on Friday, October 6th. One analyst has rated the stock with a sell rating, four have given a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $92.62.

TRADEMARK VIOLATION NOTICE: This piece was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece on another domain, it was illegally copied and reposted in violation of US and international copyright and trademark laws. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/10/19/danaher-corporation-dhr-stake-boosted-by-bluemountain-capital-management-llc.html.

Shares of Danaher Corporation (DHR) opened at 86.05 on Thursday. The firm’s 50-day moving average is $86.15 and its 200-day moving average is $84.21. The firm has a market cap of $59.78 billion, a P/E ratio of 27.47 and a beta of 1.03. Danaher Corporation has a 1-year low of $76.27 and a 1-year high of $88.62.

Danaher Corporation (NYSE:DHR) last posted its quarterly earnings data on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, topping the consensus estimate of $0.97 by $0.02. The firm had revenue of $4.51 billion for the quarter, compared to analysts’ expectations of $4.50 billion. Danaher Corporation had a return on equity of 11.15% and a net margin of 12.63%. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. During the same quarter last year, the business earned $0.90 EPS. On average, analysts anticipate that Danaher Corporation will post $3.96 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, September 29th will be given a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a yield of 0.65%. The ex-dividend date of this dividend is Thursday, September 28th. Danaher Corporation’s payout ratio is 17.83%.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.